Verona Pharma PLC VRNA
$106.91 $0.12 (0.11%) 1D
Last Updated: Oct 06, 12:00 AM·BE
Pricing for DE stocks is delayed by 24 hours
VRNA Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Verona Pharma PLC is classified as halal.
HALAL
Report Source: undefined Quarter Report
Verona Pharma PLC. Stock Analysis VRNA
Germany Health Care Mid Cap Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. The firm is focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. Its product candidate, ensifentrine, is an investigational, inhaled, small molecule and dual inhibitor of the enzyme’s phosphodiesterase 3 and 4 (PDE3 and PDE4) combining bronchodilator and non-steroidal anti-inflammatory activities in one compound. The company is engaged in developing inhaled ensifentrine for the treatment of chronic obstructive pulmonary disease (COPD). The firm's two additional formulations of ensifentrine are in Phase II development for the treatment of COPD: dry powder inhaler (DPI) and pressurized metered-dose inhaler (pMDI). The firm's wholly owned subsidiary is Verona Pharma, Inc.
Verona Pharma PLC (VRNA) Chart
Financial Metrics & Statements of Verona Pharma PLC (VRNA)
FAQ's for Verona Pharma PLC (VRNA)
- As of August 2026, Verona Pharma PLC VRNA is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Verona Pharma PLC using these criteria to determine its compliance status.
- Muslim investors may consider investing in Verona Pharma PLC if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Verona Pharma PLC by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Verona Pharma PLC may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Verona Pharma PLC on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Related Halal Stocks to Verona Pharma PLC (VRNA)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
